Edwards Lifesciences

Edwards Lifesciences Corporation
Type	Public
Traded as	NYSE: EW; S&P 500 component;
ISIN	US28176E1082
Industry	Medical device
Founded	1958
Headquarters	Irvine, California, U.S.
Key people	Michael A. Mussallem, Chairman & CEO
Products	Heart valves; Critical care technology; Cardiac surgery technology;
Revenue	$3.73 billion (2018)
Number of employees	12,800 (2018)
Website	edwards.com

Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter.[1]

Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.[2]

References

Visualizing the Sapien Heart Valve American Society of Mechanical Engineers - ASME
Edward Lifesciences Receives FDA Approval Expanding Access to Sapien Heart Valves The Wall Street Journal Online

External links

Official website

Business data for Edwards Lifesciences:

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Visualizing the Sapien Heart Valve American Society of Mechanical Engineers - ASME

[2] Edward Lifesciences Receives FDA Approval Expanding Access to Sapien Heart Valves The Wall Street Journal Online